Ftse Mib
34.302,85
-0,21%
DAX
18.529,13
-0,38%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.113,35
-2,68%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Motif Bio Plc (MTFB) Motif Bio Plc (MTFB) Notizie

MTFB

Motif Bio (MTFB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
DataOraFonteTitoloSimboloCompagnia
29/09/201508:02RNS Non-RegulatoryMotif Bio PLC Presentation of Two Posters on IclaprimLSE:MTFBMotif Bio Plc
23/09/201516:04UK RegulatoryMotif Bio PLC Issue of Shares for Exercised WarrantsLSE:MTFBMotif Bio Plc
03/09/201509:04Alliance NewsAlliance NewsMotif Bio Gets US Fast Track Designation For Iclaprim TreatmentLSE:MTFBMotif Bio Plc
03/09/201508:00UK RegulatoryMotif Bio PLC FDA Grants Fast Track Designation for IclaprimLSE:MTFBMotif Bio Plc
02/09/201508:00RNS Non-RegulatoryMotif Bio PLC Participation at Upcoming Investor EventsLSE:MTFBMotif Bio Plc
02/09/201508:00RNS Non-RegulatoryMotif Bio PLC Appointment of IR AdviserLSE:MTFBMotif Bio Plc
27/08/201511:07Alliance NewsAlliance NewsMotif Bio Loss Widens In Maiden Interim ResultsLSE:MTFBMotif Bio Plc
27/08/201508:03UK RegulatoryMotif Bio PLC Interims Results for the 6 months to 30 June 2015LSE:MTFBMotif Bio Plc
24/08/201510:56Alliance NewsAlliance NewsMotif Bio Says Report Shows "Encouraging" Results For IclaprimLSE:MTFBMotif Bio Plc
24/08/201508:00UK RegulatoryMotif Bio PLC Potent Efficacy of Iclaprim ConfirmedLSE:MTFBMotif Bio Plc
22/07/201517:32UK RegulatoryMotif Bio PLC FDA QIDP DesignationLSE:MTFBMotif Bio Plc
22/07/201510:08Alliance NewsAlliance NewsMotif Bio Says Final Condition For GBP22 Million Placing Satisfied (ALLISS)LSE:MTFBMotif Bio Plc
22/07/201508:00UK RegulatoryMotif Bio PLC Final condition of £22m placing satisfiedLSE:MTFBMotif Bio Plc
20/07/201508:00UK RegulatoryMotif Bio PLC Exercise of OptionsLSE:MTFBMotif Bio Plc
17/07/201508:40Alliance NewsAlliance NewsMotif Bio's Iclaprim Eligible For Incentives With New US DesignationLSE:MTFBMotif Bio Plc
17/07/201508:00UK RegulatoryMotif Bio PLC FDA QIDP Designation for Iclaprim for HABPLSE:MTFBMotif Bio Plc
15/07/201508:00RNS Non-RegulatoryMotif Bio PLC New Addition to Scientific Advisory BoardLSE:MTFBMotif Bio Plc
10/07/201514:37UK RegulatoryMotif Bio PLC Result of General MeetingLSE:MTFBMotif Bio Plc
23/06/201509:47UK RegulatoryAmphion Innovations PLC Partner Company raises £22 millionLSE:MTFBMotif Bio Plc
23/06/201508:58Alliance NewsAlliance NewsMotif Bio Raises GBP22 Million In Discounted Share Placing (ALLISS)LSE:MTFBMotif Bio Plc
23/06/201508:01UK RegulatoryMotif Bio PLC Placing to raise £22 million and Change of AdviserLSE:MTFBMotif Bio Plc
09/06/201510:27Alliance NewsAlliance NewsMotif Bio Annual Loss Widened Slightly Ahead Of London IPOLSE:MTFBMotif Bio Plc
09/06/201508:20Alliance NewsAlliance News*Motif Bio: Motif BioSciences 2014 Pretax Loss USD1.185M, Widened From USD1.114M IN 2013LSE:MTFBMotif Bio Plc
09/06/201508:02UK RegulatoryMotif Bio PLC Audited Non-Statutory Financial StatementsLSE:MTFBMotif Bio Plc
04/06/201517:41UK RegulatoryMotif Bio PLC Second Price Monitoring ExtnLSE:MTFBMotif Bio Plc
04/06/201517:35UK RegulatoryMotif Bio PLC Price Monitoring ExtensionLSE:MTFBMotif Bio Plc
01/06/201509:23Alliance NewsAlliance NewsMotif Bio Shares Up As It Moves Towards Iclaprim Clinical TrialsLSE:MTFBMotif Bio Plc
01/06/201508:01UK RegulatoryMotif Bio PLC Motif partners with Leading Global CROLSE:MTFBMotif Bio Plc
28/05/201511:47Alliance NewsAlliance NewsMotif Bio Gets FDA Minutes Confirming Phase III Plans For IclaprimLSE:MTFBMotif Bio Plc
28/05/201508:02RNS Non-RegulatoryMotif Bio PLC FDA Meeting Minutes Confirming Iclaprim Phase IIILSE:MTFBMotif Bio Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB

La tua Cronologia

NASDAQ
PXLW
Pixelworks
NASDAQ
CGTX
Cognition Therapeutics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network